cas 1609401-03-7|| where to buy (5-Cyclobutyl-1,2,4-oxadiazol-3-yl)methanaminehydrochloride

Nom du produit:(5-Cyclobutyl-1,2,4-oxadiazol-3-yl)methanaminehydrochloride

IUPAC Name:1-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methanamine hydrochloride

Unité d'emballage	Stock disponible	Prix($)
CM507083-1g	in stock	ǯƻŔ
CM507083-5g	in stock	ǕƻȀ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1609401-03-7 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1609401-03-7; Formule moléculaire:C7H12ClN3O; Point de fusion:-; Code SMILES:NCC1=NOC(C2CCC2)=N1.[H]Cl; Densité:

: Numéro de catalogue:CM507083; Poids moléculaire:189.64; Point d'ébullition:; N° Mdl:MFCD13186229; Stockage:

: Oxadiazoles; Oxadiazoles are a class of heterocyclic aromatic compounds with the molecular formula C2H2N2O, which have special biological activities and thermodynamic properties. Five-membered heterocyclic moieties composed of three or two heteroatoms are of great interest to researchers because these compounds show significant therapeutic potential. These heterocycles can serve as a building block for the development of novel molecular structures.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.